PAR 0.00% 30.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm CEO steps down & Appointment of MD, page-138

  1. 118 Posts.
    lightbulb Created with Sketch. 10
    Dog arthritis is very different to the human - do not make faulty conclusions based on the veterinary success. PAR data shows a big problem with severe cases. ? 20-30% get worse. IMO DYOR

    Clinical trial success is NOT a given. Neither is the FDA evaluation. FACT.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $104.9M
Open High Low Value Volume
30.0¢ 31.0¢ 29.5¢ $89.62K 294.9K

Buyers (Bids)

No. Vol. Price($)
3 20607 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 16773 1
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.